Seizure-Induced Opioid Peptides in Spinal Fluid Raised Seizure Thresholds
Cerebrospinal fluid from rats that had seizures contained opioid-like substances that protected other rats from seizures — evidence for a natural anticonvulsant system.
Quick Facts
What This Study Found
CSF from rats that had just experienced an electroshock seizure significantly raised seizure thresholds in recipient rats when injected into their brain ventricles.
This anticonvulsant activity was blocked by high-dose naloxone and by the selective delta-opioid antagonist ICI 174,864. This identified delta-opioid receptors as the mediators.
The active substance was destroyed by heat (90°C) and by trypsin (a protein-digesting enzyme), confirming it is a peptide. It passed through 10,000 dalton membranes but not 5,000 dalton membranes, putting its size between 5,000-10,000 daltons.
Post-seizure CSF had increased beta-endorphin (31 amino acids, ~3,500 daltons) but not dynorphin A, leu-enkephalin, or met-enkephalin. However, hidden met-enkephalin sequences (released by trypsin digestion of larger peptides) were found.
The size (5,000-10,000 Da) and delta-receptor specificity do not match any known opioid peptide, suggesting an undiscovered anticonvulsant opioid peptide.
Key Numbers
How They Did This
Donor rats received maximal electroshock seizure. CSF collected and injected into recipient rats' brain ventricles. Seizure threshold measured with flurothyl. Opioid antagonists tested mechanism. Heat, trypsin, peptidase inhibitors, and ultrafiltration characterized the active substance. Opioid peptide levels measured by immunoassay.
Why This Research Matters
The brain makes a protective opioid substance after seizures that prevents further seizures. This endogenous anticonvulsant has not been identified. If found and synthesized, it could become a new type of anti-seizure drug working through delta-opioid receptors, which are not targeted by current epilepsy medications.
The Bigger Picture
The brain has a built-in anticonvulsant system using opioid peptides released during seizures. Identifying and harnessing these natural molecules could lead to new epilepsy treatments.
What This Study Doesn't Tell Us
The active substance was not fully identified. CSF transfer experiments are artificial. The amount of protection was moderate. Only one seizure model was tested. The relationship between the beta-endorphin increase and the anticonvulsant activity was unclear.
Questions This Raises
- ?What specific opioid peptide is the anticonvulsant agent?
- ?Could synthetic versions prevent seizure recurrence?
Trust & Context
- Key Stat:
- Transferable seizure protection Post-seizure CSF raised seizure thresholds in naive recipient rats
- Evidence Grade:
- Preliminary animal study with elegant transfer experiment but unidentified active substance.
- Study Age:
- Published in 1988 — key evidence for endogenous opioid-based anticonvulsant mechanisms.
- Original Title:
- Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid.
- Published In:
- Brain research, 456(1), 139-46 (1988)
- Authors:
- Tortella, F C, Long, J B(2)
- Database ID:
- RPEP-00096
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does the brain protect itself from seizures?
During seizures, the brain releases opioid peptides into the spinal fluid that can raise the threshold for future seizures. This is a natural protective mechanism.
Could this help epilepsy patients?
If the specific anticonvulsant opioid peptide can be identified and synthesized, it could become a new class of epilepsy medication based on the brains own protective chemistry.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00096APA
Tortella, F C; Long, J B. (1988). Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid.. Brain research, 456(1), 139-46.
MLA
Tortella, F C, et al. "Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid.." Brain research, 1988.
RethinkPeptides
RethinkPeptides Research Database. "Characterization of opioid peptide-like anticonvulsant activ..." RPEP-00096. Retrieved from https://rethinkpeptides.com/research/tortella-1988-characterization-of-opioid-peptidelike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.